ClinConnect ClinConnect Logo
Search / Trial NCT05457179

Physical Activity to Reduce Cardiometabolic Risk in Adults With Serious Mental Illness (PARCS) Study

Launched by KANSAS STATE UNIVERSITY · Jul 10, 2022

Trial Information

Current as of July 01, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

Adults with serious mental illness or serious mental illness (SMI) suffer from drastically higher rates of premature mortality (as much as a 10-25 years reduction in life expectancy) compared to the general population. Co-morbid medical conditions (i.e., heart disease, diabetes) are a fundamental cause. The iatrogenic cardiometabolic effects associated with antipsychotic drugs complicate matters. Underlying modifiable cardiometabolic risk factors (e.g., obesity, hypertension, poor physical fitness) are more prevalent and manifest earlier in the lifecourse in persons with SMI compared with t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Authorized for peer group treatment through the behavioral health facility
  • Medically cleared to participate in physical activity (if indicated by ACSM 11th Edition pre-exercise participation screener)
  • Exclusion Criteria:
  • Under 18 years of age
  • Unable to obtain physician clearance (if indicated by ACSM 11th Edition pre-exercise participation screener)

About Kansas State University

Kansas State University (KSU) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KSU leverages its diverse expertise in veterinary and human medicine, agricultural sciences, and public health to conduct rigorous clinical research. The university is committed to ethical standards, participant safety, and the dissemination of impactful findings that contribute to the scientific community and society at large. Through its clinical trials, KSU aims to address pressing health challenges and foster the development of new therapeutic strategies.

Locations

Augusta, Georgia, United States

Junction City, Kansas, United States

Patients applied

0 patients applied

Trial Officials

Gina M Besenyi, MPH, PhD

Principal Investigator

Kansas State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials